COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors
Alessandro Leonetti, Francesco Facchinetti, Teresa Zielli, Elena Brianti, Marcello Tiseo
Topics & Concepts
MedicinePandemicCoronavirus disease 2019 (COVID-19)Lung cancerCancerSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Internal medicinePneumoniaOutbreakDiseaseOncologyVirologyInfectious disease (medical specialty)COVID-19 and healthcare impactsCancer Immunotherapy and BiomarkersEconomic and Financial Impacts of Cancer